Edition:
United Kingdom

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

0.41USD
15 Feb 2019
Change (% chg)

$0.02 (+4.41%)
Prev Close
$0.39
Open
$0.40
Day's High
$0.41
Day's Low
$0.40
Volume
19,600
Avg. Vol
100,332
52-wk High
$17.76
52-wk Low
$0.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.136
Jun '18 0.00 -0.405
Mar '18 0.00 -0.673
FY 2017 Dec '17 0.00 -0.879
Sep '17 0.00 -0.366
Jun '17 0.00 -0.444
Mar '17 0.00 -0.420
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) 4.04 10.14 5.26
Price to Tangible Book (MRQ) 4.05 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 50.05 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -36.57 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 24.85 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 9.43 3.50 3.08
LT Debt to Equity (MRQ) 20.32 18.65 11.38
Total Debt to Equity (MRQ) 23.99 31.33 16.12
Interest Coverage (TTM) -54.28 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.40 12.87
Operating Margin (TTM) -- -184.63 6.20
Operating Margin - 5 Yr. Avg. -- -126.89 8.31
Pre-Tax Margin (TTM) -- -175.33 7.16
Pre-Tax Margin - 5 Yr. Avg. -- -132.68 8.61
Net Profit Margin (TTM) -- -182.03 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.07 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,654,601 842,398,385
Net Income/Employee (TTM) -1,482,231 562,114 99,842,801
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.23 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -43.75 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -48.11 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 66.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Edge Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.24 1.61 57 99
13 Week 9.08 3.77 64 95
26 Week 24.30 14.85 71 98
52 Week 1.66 -13.84 52 72
YTD -11.60 -22.37 33 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 27.85%
# of Holders: 38
Total Shares Held: 8,726,435
3 Mo. Net Change: -1,110,330
# New Positions: 3
# Closed Positions: 11
# Increased Positions: 7
# Reduced Positions: 17
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.